Candle Partners, an investment banking & advisory service for M&A among others, has closed many deals in the healthcare space. Ankit Poddar, Director, Candle Partners spoke to Thomas C Thottathil, Editor, Indianpharmapost.com about the prospects for the industry.
The company also raised Rs 270 crore investment from Temasek in 2019
The new framework collaboration will support due diligence into ALSA’s potential investments, which will assist with their investment de-risking
Pharma exports in 2021-22 sustain a positive growth despite global trade disruptions
The plant is expected to start commercial operations from Q4FY24
The round also saw participation from US-based fund 57 Stars, a few prominent angel investors, existing investors Stellaris Venture Partners, Vertex Ventures, and Alteria Capital
These bulk orders will contribute to the topline of the company as well as help in improving EBITDA of the company
Investment and innovation opportunities in the field of AYUSH are limitless : Sarbananda Sonowal
Strive to empower public health with disinfection robotics solutions in post-pandemic era
Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company's global growth journey
Subscribe To Our Newsletter & Stay Updated
